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Modulation of capsid assembly by small molecules has become a central concept in
the fight against viral infection. Proper capsid assembly is crucial to form the high
molecular weight structures that protect the viral genome and that, often in concert
with the envelope, allow for cell entry and fusion. Atomic details underlying assembly
modulation are generally studied using preassembled protein complexes, while the
activity of assembly modulators during assembly remains largely open and poorly
understood, as necessary tools are lacking. We here use the full-length hepatitis B virus
(HBV) capsid protein (Cp183) as a model to present a combination of cell-free protein
synthesis and solid-state NMR as an approachwhich shall open the possibility to produce
and analyze the formation of higher-order complexes directly on exit from the ribosome.
We demonstrate that assembled capsids can be synthesized in amounts sufficient for
structural studies, and show that addition of assembly modulators to the cell-free reaction
produces objects similar to those obtained by addition of the compounds to preformed
Cp183 capsids. These results establish the cell-free system as a tool for the study of
capsid assembly modulation directly after synthesis by the ribosome, and they open the
perspective of assessing the impact of natural or synthetic compounds, or even enzymes
that perform post-translational modifications, on capsids structures.
Keywords: cell-free protein synthesis, NMR, proton detection, capsid, HBV—hepatitis B virus, assembly
modulation
INTRODUCTION
The hepatitis B virus (reviewed in Nassal, 2008; Seeger and Mason, 2015) is a small enveloped
DNA virus whose genomic information encodes few genes: the envelope proteins S, M and L
(collectively known as hepatitis B surface antigen/HBsAg), the core protein (Cp), the polymerase
(P), and the X protein (HBx). The icosahedral HBV capsid is formed by Cp, the different
functions of which are driven by phosphorylation/dephosphorylation of its C-terminal domain
(Kann and Gerlich, 1994; Gazina et al., 2000; Blondot et al., 2016; Ludgate et al., 2016; Heger-
Stevic et al., 2018b). Cp is a 183-residue protein with two domains: the assembly domain
that forms the contiguous capsid shell, and the C-terminal domain (CTD, residues 150–183)
that amongst other functions is responsible for RNA packaging (Birnbaum and Nassal, 1990).
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The two domains are connected by a linker (residues 141–149). In
infected cells, the core proteins pack the pregenomic (pg) RNAon
assembly (Nassal, 1992), as well as a copy of the viral polymerase
(Bartenschlager et al., 1990). Inside the capsid, the pgRNA is
then transcribed to double-stranded relaxed circular (rc) DNA,
generating mature capsids ready for envelopment.
The core protein thus plays essential roles at different
stages of the virus life cycle and currently emerges as a
promising drug target (Zlotnick et al., 2015) (recently reviewed
in Yang and Lu, 2018; Nijampatnam and Liotta, 2019), with
development of corresponding, effective antiviral agents well
under way. Molecules targeting Cp are often called capsid
assembly modulators or core protein allosteric modulators
[CAMs (Zlotnick et al., 2015), CpAMs (Zlotnick et al., 2015)].
Their major mechanism has been described either to be the
acceleration of capsid assembly kinetics, which promotes the
formation of morphologically normal capsid structures, but
results in a failure to package pgRNA, as observed for example
for AT-130. Or induction of aberrant oversized Cp structures
(Diab et al., 2018), sequestering capsids from their functions, as
observed for heteroaryldihydropyrimidines (HAP). To avoid the
confusion in the literature as to which mechanism of action is to
be called class I vs. class II (Lahlali et al., 2018; Yang et al., 2019)
we herein use a tentative new nomenclature whereby CAM-N
refers to modulators causing normal and CAM-A to modulators
causing abnormal capsid structures. CAMs interfere with several
central steps in the viral life cycle. They have been shown to
prevent nuclear transport of capsids blocking de novo formation
of covalently closed circular (ccc) DNA (Nassal, 2015); they
are active pan-genotypic, and active against nucleoside analog
resistant virus mutants. Several CAMs of both classes are being
evaluated in clinical trials (Durantel and Zoulim, 2016; Feng et al.,
2018; Schinazi et al., 2018).
The capsid structure has been investigated by a range of
structural-biology techniques. With the exception of a 3.3
Å X-ray structure (Wynne et al., 1999) of the N-terminal
assembly domain, structures of the full-length capsid have been
determined by cryo-electron microscopy (cryo-EM) (Crowther
et al., 1994; Bottcher et al., 1997), the latest to date at 2.7 Å
resolution (Böttcher and Nassal, 2018). The different cryo-EM
structures have mostly been described as similar to the X-ray
structure, although small differences have been attributed to the
absence/presence of the CTD (Yu et al., 2013), the presence of
RNA as opposed to DNA (Roseman et al., 2005), or to drug
binding (Schlicksup et al., 2018). Importantly, while the CTD is
present in the structures solved, it is flexible and has not a defined
density (Zlotnick et al., 1997; Patel et al., 2017).
Eight structures of capsids with antiviral compounds bound
have been determined (Bourne et al., 2006; Katen et al.,
2013; Klumpp et al., 2015; Qiu et al., 2016; Venkatakrishnan
et al., 2016; Zhou et al., 2017; Schlicksup et al., 2018).
All characterized Cps carried mutations, and none contained
the CTD. The most commonly used constructs were Cp150
carrying an unnatural C-terminal cysteine plus triple Cys
to Ala mutations depleting the protein from all endogenous
cysteine residues (3CA-Cp150C). These mutations maintain
the symmetry used in cryo-EM reconstruction of capsid
structures, as the covalent intra-capsid cross linking via the
C-terminal cysteine counterbalances the drastic destabilizing
effects of the investigated HAP1 CAM. The increased stability
of the modified capsids enabled X-ray structures with a decent
resolution of around 4 Å (Venkatakrishnan et al., 2016). A
higher resolution (1.7 Å) structure was obtained by X-ray
crystallography employing the Cp Y132A mutation (Qiu et al.,
2016) that abrogates capsid formation. Instead, Y132A induces
flat hexameric structures (trimers of dimers) which form
excellent crystals but clearly do not reflect the structure of the
assembled capsid which is important when considering CAM
action (Schlicksup et al., 2018).
Overall it remains unclear, at a molecular level, whether
assembly modulators act similarly on preassembled vs. nascent
capsids. One approach to address this issue is to disassemble
capsids into dimeric Cp subunits which then are incubated
with the CAM under assembly-favoring conditions, e.g., high
concentrations of salt (Schlicksup et al., 2018). Such non-
physiological conditions could possibly interfere with assembly
modulation. Studying assembly modulation instead directly at
the exit from the ribosome, under conditions close to the
cellular environment, is thus of high interest. This can principally
be achieved using cell-free protein synthesis (CFPS). CFPS
of the HBV capsid has been described early-on by Lingappa
and coworkers (Lingappa et al., 1994) who produced viral
capsids in wheat-germ extract cell-free system (WGE-CF). Their
study was motivated by the question how capsid assembly is
influenced, under near-physiological concentrations, by cellular
proteins, the cytoplasmic environment, and organelles (Lingappa
et al., 1994). Indeed, in cells, the concentration of capsid
protein is relatively low (an estimate of the steady-state HBc
concentration in stably transfected hepatoma cells established
ca. 300 nM Ludgate et al., 2016). Another important point
is that assembly and its modulation with purified protein
differs from that in cells where capsid formation is linked
to Cp translation (Lingappa et al., 2005) and occurs in the
presence of chaperones. A rabbit reticulocyte lysate (RRL) cell-
free system has been recently applied to study HBV capsid
assembly under more physiological conditions; Cp is expressed
with low concentrations and assembles under near-physiological
conditions (Ludgate et al., 2016; Liu andHu, 2018). However, this
system generally does not yield quantities [about 250 ng per mL
reaction (Ludgate et al., 2016)] sufficient for structural studies,
notably by NMR.
While cell-free expression can provide a means to sample
capsid modulation directly at the exit from the ribosome, the
approach remains limited without ameans to structurally analyze
the products at atomic resolution. Solid-state NMR can study
full-length, wild-type capsids simply as sediments resulting from
ultracentrifugation (Goldbourt et al., 2007; Han et al., 2010;
Andreas et al., 2016). Notably, NMR has low requirements on
sample properties: they neither need to be crystalline, nor show
symmetry, only local order. This allows comparisons of the
NMR signals of a variety of preparations and forms, and to
conclude about structural and dynamic differences. NMR can
in principle provide spectral fingerprints relating to structural
features for both normal and abnormal capsid induced by
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modulators, including for capsids carrying modifications like
phosphorylation. As the necessary basis for further studies, we
have recently assigned the NMR signals of the HBV capsid (Lecoq
et al., 2018b), revealing residues which conformationally adapt
to allow for the dimer-to-capsid transition. Also, we identified
the residues of the core protein which form the hinges that
accommodate formation of the quasi-equivalent five-fold and
quasi-six-fold vertices in the capsid (Lecoq et al., 2018a).
The classical approach to solid-state NMR involving carbon-
13 detection is difficult to apply to the milligram quantities CFPS
can easily produce. The recent development of proton-detection
techniques opens the way for such studies, as it reduces the
necessary protein amount by almost two orders of magnitude,
to submilligram quantities (Böckmann et al., 2015; Lecoq et al.,
2019). We have recently shown that the duck hepatitis B virus
(DHBV) subviral particles can auto-assemble in the cell-free
system and be analyzed by NMR (David et al., 2018). We show
here that this same system can be used to produce wild-type
full-length Cp HBV capsids, and do so in amounts compatible
with solid-state NMR structural investigations, including the
recording of 3D spectra with sufficient resolution and sensitivity.
We show that the phenotypes produced by CAM-N and CAM-
A are similar to those produced using purified capsids from
E. coli. Hence, WGE-CF synthesis of capsids combined with
solid-state NMR provides a valuable tool to study the effects of
capsid assembly modulation on proteins directly at the exit of
the ribosome.
MATERIALS AND METHODS
Plasmids
The genescorresponding either to the full-length core protein
(Cp183) or to its truncated form Cp149 were cloned into the
pEU-E01-MCS vector (CellFree Sciences, Japan) for WGE-CF
expression. The plasmids were amplified in DH5α bacteria,
and purified using a NucleoBond Xtra Maxi kit (Macherey-
Nagel, France). An additional purification step was performed
with a phenol/chloroform extraction to ensure the purity of the
plasmid according to the recommendations of CellFree Sciences
(Yokohama, Japan).
mRNA Transcription
Transcription was performed according to Takai et al. (2010)
in 1.5mL Eppendorf tubes using 100µg/mL plasmid, 2.5mM
NTP mix (Promega), 1 U/µL SP6 RNA Polymerase (CellFree
Sciences), and 1U/µL RNase inhibitor (CellFree Sciences)
in transcription buffer (CellFree Sciences) containing 80mM
Hepes-KOH pH 7.6, 16mM magnesium acetate, 10mM DTT
and 2mM spermidine. After incubation for 6 h at 37◦C, mRNA
was used directly for translation.
Wheat Germ Cell-Free Protein Synthesis
Non-treated durum wheat seeds (Sud Céréales, France) were
used to prepare home-made WGE as described in Fogeron
et al. (2017), according to the protocol of Takai et al. (2010)
with minor modifications. Translation was performed using the
bilayer method as described in Takai et al. (2010), Fogeron
et al. (2017) for small scale expression tests in the presence
of compounds, or using the dialysis mode as described in
David et al. (2018) for larger scale production followed by
isolation on a sucrose density gradient. For the bilayer method,
the bottom layer (20 µL) corresponding to the translation
mixture contains per well 10 µL of mRNA, 10 µL of WGE, 40
ng/µL of creatine kinase and 6mM of amino-acid mix (0.3mM
per amino acid, average concentration). The upper layer (200
µL) corresponding to the feeding buffer contains SUB-AMIX
NA (CellFree Sciences; 30mM Hepes-KOH pH 7.6, 100mM
potassium acetate, 2.7mM magnesium acetate, 16mM creatine
phosphate, 0.4mM spermidine, 1.2mM ATP, 0.25mM GTP,
and 4mM DTT), and 6mM of amino acid mix (0.3mM per
amino acid, average concentration). For Cp183 expression in the
presence of different compounds, 10 nmol of antiviral (dissolved
in DMSO at a concentration of 10mM) was added into 200 µL
feeding buffer and translation was performed at 22◦C for 16 h.
For large-scale production, dialysis cassettes with a volume
of either 500 µL or 3mL, depending on the production scale,
and a MWCO of 10 kDa were used. The translation mixture
contained ½ by volume of feeding buffer, 1/3 of mRNA, 1/6
of WGE, 40 ng/µL of creatine kinase, 0.3mM of amino-acid
mix. The feeding buffer (either 20mL or 124mL for a 500-µL
or a 3-mL dialysis cassette, respectively) contains SUB-AMIX
NA (CellFree Sciences) as described above, supplemented with
0.3mM of amino-acid mix. The dialysis cassette containing the
translation mix was soaked in the feeding buffer, and incubated
for 16 h under shaking at 60 rpm, 22◦C. A mix containing
all twenty isotopically labeled amino acids (Cambridge Isotope
Laboratory) was used for the production of 13C-15N-Cp183 for
NMR studies in a 3 mL-translation reaction experiment.
Isolation of the Capsids on a Sucrose
Density Gradient
The total cell-free reactionmixture (CFS) was treated with 25,000
units/mL of benzonase for 30min at room temperature before
centrifugation at 20,000 g, 4◦C for 30min. The supernatant (SN)
was loaded onto a discontinuous sucrose gradient with layers of
10, 20, 30, 40, 50, and 60% sucrose (w/v), each with a volume of
350 µL for a production in a 500-µL cassette. For the production
of a 13C-15N-Cp183 sample in a 3-mL dialysis cassette, the
supernatant (SN) was split into two fractions and loaded onto
two sucrose gradients with layers of 10, 20, 30, 40, 50, and 60%
sucrose (w/v), each with a volume of 1.5mL. The gradients were
centrifuged at 200,000 g, 4◦C for 12 h. After centrifugation, the
different sucrose fractions were harvested and analyzed by SDS-
PAGE and Western blotting, as well as by electron microscopy
after negative staining as described below.
Capsids From E. coli
Cp183 capsids used as reference for negative stain EM with
CAMs were obtained from BL21∗-CodonPlus (DE3) cells using
plasmid pRSF-T7-HBc183opt. Expression and purification were
done as previously reported (Heger-Stevic et al., 2018a; Lecoq
et al., 2018b). In brief, protein was expressed overnight after
induction with 1mM IPTG at 20◦C, and cell lysate was separated
with 10–60% sucrose gradient. Cp183 capsids were precipitated
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after the sucrose gradient by 40% saturation ammonium sulfate,
and resuspended in final buffer (50mM Tris pH 7.5, 5mM DTT,
1mM EDTA, 5% sucrose). The interaction between preformed
capsids and compounds was performed with a molar ratio of
Cp183 monomer: compound of 1:4, at 37◦C for 2 h.
Rotor Filling and NMR Data Acquisition
Four different Cp183 NMR samples were prepared: two from
cell-free protein synthesis, one synthesized using 13C/15N, and
the other one 2H/13C/15N amino acids, resulting in a protonated
sample, and a deuterated, but 100% protonated on exchanging
protons, as synthesis is carried out in H2O; and for reference
two samples from E. coli expression, one deuterated and back
exchanged on exchangeable sites, and one protonated (Heger-
Stevic et al., 2018a; Lecoq et al., 2018b). NMR samples were filled
into 0.7mm rotors as sediment obtained by ultracentrifugation
directly into the rotor (Böckmann et al., 2009) at 200,000 g for
approximately 16 h at 4◦C, yielding approximately 0.5mg of
sediment. As an internal chemical-shift reference, about 30 µL
of saturated (0.3M) 4,4-dimethyl-4-silapentane-1-sulfonic acid
(DSS) was added to the protein solution before sedimentation.
On each of the samples a two-dimensional (2D) fingerprint
hNH spectrum was recorded. On the protonated, uniformly
13C-15N labeled cell-free produced sample, an hCANH 3D
(Penzel et al., 2015) was recorded in addition. All spectra
were acquired on a wide-bore 850 MHz Bruker Avance III
spectrometer with a 0.7mm triple-resonanceMAS probe (Bruker
Biospin) operated at 100 kHz MAS. Magic angle and shim for
this probe were set using a 0.7mm rotor with glycine ethylester
by optimizing the intensity and J-coupling based splitting of the
CO resonance (Penzel et al., 2018). The sample was cooled with
a BCU (Bruker Cooling Unit) gas flow of 400 l/h with a VT
(Variable Temperature) set to 272K, corresponding to a sample
temperature of approximately 22◦C, extrapolated from the water
chemical shift in a 1H 1D (Gottlieb et al., 1997; Böckmann
et al., 2009). Detailed acquisition parameters can be found in
Supplementary Table 1.
NMR Data Processing
TopSpin 4.0.3 (Bruker Biospin) was used for the data acquisition
and processing. 2D hNH spectra were processed with 1,024
points in 1H dimension (corresponding to 12.9ms of acquisition
time) and zero filling was applied to, respectively, 4,096 points
in 1H and 1,024 points in 15N dimension. The 3D hCANH
was processed with zero filling to, respectively 2m048 points in
1H, 128 points in 15N, and 256 points in 13C dimensions. All
spectra were apodized with a shifted sine-bell window function
using SSB = 3.5 in TopSpin. Linear prediction to twice the
recorded number of points was applied in the 15N dimension for
2D hNH spectra of the protonated capsids produced by CFPS,
and the deuterated E. coli capsids, in order to reach a similar
number of points as acquired for the other samples. Spectral
analyses were performed using the CcpNmr Analysis package
2.4.2 (Stevens et al., 2011). The proton linewidths were obtained
using the parabolic fit function integrated on CcpNmr on six
isolated peaks in the hNH spectra. The errors given represent
the standard deviations between the six values. Signal-to-noise
ratio were calculated on the bulk signals from 1D hNH spectra
recorded and processed with similar parameters and divided by
the square root of the number of scans.
SDS-PAGE and Western Blotting Analysis
The expression of Cp183 was assessed by 15% Coomassie
blue stained SDS–PAGE and Western blotting as described in
Fogeron et al. (2015). A polyclonal rabbit antiserum against the
N-terminal domain of the HBV core protein (a-c149) was used
to detect both Cp149 and Cp183 on blots.
Negative Staining Electron Micrographs
Samples for electron microscopy were negatively stained as
described in Lecoq et al. (2018b). Briefly, 5 µL of each fraction
were loaded on a carbon-coated grid (EMS Microscopy) and
incubated for 2min at room temperature. Remaining liquid was
drained using Whatman paper. Grids were negatively stained on
a 50-µL drop of 2% phosphotungstic acid (pH = 7) for 2min at
room temperature and observed with a JEM-1,400 transmission
electron microscope operating at 100 kV.
RESULTS
Full-Length Cp183 but Not CTD-Less
Cp149 Self-Assembles Upon Cell-Free
Protein Synthesis
CFPS of the core protein was performed for both Cp149 and
Cp183. The protein was foundmainly in the soluble fraction after
centrifugation, as indicated in Western blots in Figures 1A,B.
The protein band is partly visible in the total CFS fraction of the
Coomassie blue gel. Enrichment via a sucrose gradient reveals
that Cp149 stays mainly in the load and in the 10% sucrose
fraction, indicating the protein remained in an unassembled,
probably dimeric state. Accordingly, the electron micrograph of
the 10% fraction (Figure 1A, blue asterisk), showed only very few
capsids. In contrast, Cp183 sedimented largely into the 50 and
60% sucrose fractions (Figure 1B, red asterisk), as expected when
capsids have been formed. EM inspection revealed numerous
auto-assembled Cp183 capsids with a diameter of about 30 nm,
as also observed for capsids assembled in E. coli (Gallina et al.,
1989; Lecoq et al., 2018b).
Upon expression in E. coli, both Cp183 and the CTD-
less Cp149 variant auto-assemble into capsids. Only full-length
protein packages RNA, while Cp149 capsids remain empty
(Birnbaum and Nassal, 1990). Both types of capsids can be
isolated from bacteria by a set of purification steps (Heger-Stevic
et al., 2018b; Lecoq et al., 2018b), with Cp149 giving particularly
high yields (100mg per liter of culture, compared to 20 mg/L
for Cp183). The capsids can be disassembled using either urea
(Cp149) or guanidinium chloride (Cp183) (Zlotnick et al., 1997;
Porterfield et al., 2010). Reassembly is concentration dependent,
and in vitro assembly of the full-length protein needs addition
of nucleic acids which are non-sequence specifically packaged
(Porterfield et al., 2010). Failure of Cp149 to assemble upon
WGE-CF synthesis is likely due to the higher concentrations
this protein needs for assembly, while the interaction between
the positively-charged Cp183 CTD with the negatively-charged
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FIGURE 1 | CFPS and sucrose gradient isolation of Cp149 (A) and Cp183 (B). Shown are from top to bottom, Coomassie blue stained gels, western blots, and
negative staining electron micrographs of protein-containing fractions. CFS: total cell-free reaction mixture; P and SN: pellet and supernatant obtained after
centrifugation of the CFS at 20,000 g, 4◦C for 30min; 0–60%: fractions from the sucrose gradient. Scale bar = 200 nm.
nucleic acids enables Cp183 assembly at concentrations as low as
5 nM (Klein et al., 2004). Failure of Cp149 to assemble has also
been observed in rabbit reticulocyte extract (Ludgate et al., 2016).
Milligram Amounts of 13C/15N Labeled
Cp183 Capsids Can be Produced in
Protonated and Deuterated Form
For large-scale production (∼1 milligram) needed for NMR
sample preparation, CFPS was carried out in dialysis reactions,
as described for the duck HBV envelope subviral particle
synthesis (David et al., 2018). Either protonated or deuterated,
HN protonated Cp183 was prepared, with the latter referred
to in the following as dCp183. In the large-scale synthesis,
more protein was found in the pellet compared to the small-
scale synthesis, likely due to higher concentrations. On sucrose
gradient isolation, migrated to the 60 % fraction (Figures 2A,B).
The preparation using the deuterated amino acids shows higher
purity, which might be due to a slightly different migration
behavior of the deuterated protein in the sucrose gradient.
EM inspection revealed abundant capsids in both preparations
(Figures 2C,D).
Cell-Free Synthesized Capsids Can be
Analyzed by NMR
Conformational details can be revealed by NMR in so-
called fingerprint spectra, which show either in two (2D) or
three dimensions (3D) the typical signature of the protein
preparation. Structural variations can be sensitively identified
by comparing spectra recorded under different conditions, and
analyzing the differences in the observed chemical shifts, i.e.,
the NMR frequencies (Williamson, 2013). An opportunity of
the combination of CFPS and NMR is the fact that only the
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FIGURE 2 | Analysis of CFPS and sucrose gradient isolation on 15% SDS-PAGE gels of (A) 13C, 15N and (B) 2H, 13C, 15N isotopically labeled dCp183. CFS: total
cell-free reaction mixture; P and SN: pellet and supernatant obtained after centrifugation of the CFS at 20,000 g, 4◦C for 30min; 0–60%: fractions from the sucrose
gradient. Negative staining electron micrographs display the 13C, 15N labeled (C) and 2H, 13C, 15N labeled (D) capsids from the 60% sucrose fractions. Scale bar =
100 nm.
synthesized protein, which is the sole isotopically labeled protein,
will be observed in the spectra. The use of a simple sucrose
gradient concentration step thus might not produce perfectly
pure protein; still, only the protein of interest will produce
signal in the spectra. A possible drawback might lie in a loss of
signal-to-noise ratio (SNR) in the spectra, since the NMR sample
container (rotor) also might contain residual contaminating
proteins (Figure 2A). It is thus important to establish whether
protein samples prepared by CFPS are indeed compatible with
the recording of 2D and in particular 3D spectra in a reasonable
amount of time.
The hNH 2D correlation spectrum recorded in 16 h on the
protonated cell-free Cp183 displays a highly similar spectrum to
the one recorded on the capsids purified from E. coli (Figure 3A
and Figure S1) in 10 h. The NMR signal amplitude of the
sample from CFPS is about 35% of the spectra obtained on the
preparation from purified E. coli protein recorded under the
same experimental conditions. As both rotors were full with
protein sediment, this means that the contaminating unlabeled
proteins from theWGE fill almost 2/3 of the rotor. A 3D hCANH
spectrum was recorded on the sample in 4 days and 15 h, and an
overlay of all 3D NH planes onto the 2D NH plane shows that
most signals in the 2D hNH spectrum are also observed in the
3D (Figure 3B).
The 2D spectrum recorded on the deuterated sample is shown
in Figures 3C,D. SNR is very favorable in this sample, since the
deuterated protein surprisingly showed better purity (Figure 2B).
The spectrum reveals narrower lines than the spectrum from the
protonated sample, as also observed in model systems (Penzel
et al., 2019) and, in particular, also in capsid preparations purified
from E. coli (Lecoq et al., 2019): 140Hz on average for the
protonated vs. 100Hz for the deuterated sample, as measured
on six isolated resonances. The SNR and proton linewidths for
the four samples are summarized in Figures 3E,F, respectively.
It reveals that CFPS samples show a greater variability in
sample amounts than the well-established E. coli samples;
further experience is needed to evaluate parameters allowing
reproducible sample preparation using CFPS. The proton
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Wang et al. Cell-Free Capsid Assembly
FIGURE 3 | Comparisons of NMR spectra between the capsids from CFPS and capsids purified from E. coli. (A) Overlay of the 2D hHN spectra of the protonated
Cp183 capsids from CFPS (in blue) and purified from E. coli (in gray); (B) overlay of the 2D planes from the 3D hCANH spectrum recorded on the protonated Cp183
CFPS capsids; (C) 2D hNH spectrum of the deuterated Cp183 CFPS capsids; (D) overlay of the 2D hNH spectra of the deuterated capsids from CFPS (in purple) and
purified from E. coli (in orange), with resonances not observed in the E. coli sample highlighted as black circles. Spectra are shown individually in Figure S1. (E)
Comparison of signal-to-noise ratios of the different samples; (F) comparison of proton linewidths in the different samples. The averages over the two protonated and
the two deuterated samples are indicated.
linewidths are virtually similar between the two protonated and
two deuterated samples, indicating that production by CFPS or
E. coli expression does not make a difference with respect to
linewidth and therefore conformational homogeneity.
Importantly, several peaks are present in the cell-free
synthesized dCp183 which could not be observed in the
deuterated sample purified from E. coli, as emphasized in
Figure 3D. The origin of this observation lies in the incomplete
back-exchange in E. coli produced samples. Indeed, when
deuterated protein is expressed in E. coli, synthesis takes place in
D2O, and exchange of deuterons to protons is achieved during
the subsequent purification steps, carried out in H2O. Still,
solvent-inaccessible deuterons can remain in the protein over
long periods of time, and often denaturation/renaturation of the
protein is applied to complete proton exchange important for
NMR observation. However, this step can be very difficult for
more complex proteins, and the present experiment highlights
this interesting feature of CFPS, where the protein is synthesized
from the beginning in H2O, and deuteration is achieved not
via metabolism, but by addition of deuterated amino acids to
the cell-free reaction. This results in fully protonated amide
(and exchangeable sidechain) protons in the synthesized protein,
which is essential for the recording of NMR spectra showing
resonances for all amino acids.
Capsids Can be Synthesized in the
Presence of Antiviral Compounds
CFPS proceeds in an open system, and a variety of substances
can be added to the reaction mixture. We added different
capsid assembly modulators to the reaction, in order to
analyze whether this produces comparable phenotypes to those
observed on capsids purified from E. coli. Figure 4A shows the
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Coomassie blue stained gels of the cell-free solutions without
compounds, in the presence of DMSO used for solubilization
of the antiviral, and in presence of AT-130, JNJ-623 (CAM-N),
and JNJ-890 (CAM-A). The corresponding Western blots are
shown in Figure 4B. None of the compounds inhibited protein
synthesis. We analyzed the total cell-free solutions, without any
concentration or purification, under the electron microscope,
and compared the observed capsids as shown in Figures 4C–G
with the ones obtained from addition of compounds to capsids
purified from E. coli, shown in Figures 4H–J. One can see in
the micrographs that the resulting objects closely resemble those
obtained by addition to preformed capsids: DMSO vehicle and
CAM-Ns produced no visible effect, whereas CAM-As showed
the typical disruption of capsids also reported in the literature
(Berke et al., 2017; Lahlali et al., 2018). Notably, the presence
of AT-130 lead to poorer contrast in the EM micrographs of
both preparations.
CONCLUSIONS
We have synthesized HBV viral capsids in a eukaryotic wheat
germ cell-free system in sufficient amounts for structural
analyses, including by solid-state NMR. We have shown that
the full-length Cp183 protein auto-assembles in the cell-
free system to form icosahedral capsids virtually identical to
those obtained upon bacterial expression. This finding opens
the possibility to produce isotope labeled samples, both in
protonated and deuterated forms, for advanced proton-detected
NMR experiments. The spectra recorded on the samples
FIGURE 4 | CFPS of Cp183 in presence of different compounds. (A,B) 15% SDS-PAGE (A) and Western blot (B) analysis on Cp183 protein produced in 220-µL
CFPS system with 10 nmol drugs dissolved in 1 µL DMSO. The lanes of two controls, referred as blank and +DMSO, and productions with compounds are
highlighted on the top. Electron microscopy (negative staining) analysis of cell-free products of the blank (C), +DMSO (D), +AT-130 (E), +JNJ-632 (F), +JNJ-890
(G), as well as capsids from E.coli incubated with AT-130 (H), JNJ-632 (I), JNJ-890 (J), are shown on the right. Scale bar = 50 nm.
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showed sufficient signal-to-noise to analyze 2D and 3D spectral
fingerprints and thus conformational changes. Importantly, this
enables investigations of capsid interactions directly on synthesis
with assembly modulators, other natural compounds such as
lipids, or chaperones and enzymes that might be relevant in
vivo. We demonstrated this at the example of three capsid
assembly modulators from different chemical classes, which
induced similar structural changes in capsids synthesized and
assembled in presence of the compounds and in preformed
capsids isolated from E. coli. Hence the influence of small
molecules on the capsid can now also be assessed on assembly
after exit from the ribosome, on the relevant full-length protein,
without extensive purification steps, and in the presence of
nucleic acids.
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